Stock Analysts

General Dynamics Posts Upbeat Q4 Earnings, Backlog Robust

General Dynamics Corporation ( GD ) announced fourth-quarter 2014 earnings from continuing operations of $2.19 per share on a diluted basis, comfortably surpassing the Zacks Consensus Estimate of $2.10 by 4.3%. Earnings also increased 24.4% from the prior-year figure of $1.76, backed by improved operating margins. Full year earnings from continuing operations came in at $7.83 per share, surpassing the Street consensus of $7.75 and improving 11.4% year over year […]

Stock Analysts

Abiomed Q3 Earnings Impress; Impella RP Gets FDA Approval

Shares of Danvers, MA-based Abiomed Inc. ( ABMD ) surged as much as 27.13% or $10.48 in after hours trading following the release of impressive third-quarter fiscal 2015 financial numbers as well as the receipt of an FDA HDE approval for its Impella RP System. Abiomed announced that the FDA approved its Impella RP (Right Percutaneous) System under a Humanitarian Device Exemption (HDE). […]